About Legend Biotech Corp
Legend Biotech (NASDAQ:LEGN) is a global biotech firm focused on discovering, developing, and commercializing cell therapies for oncology and other life-threatening diseases. Their robust pipeline includes candidate treatments that leverage innovative technologies, particularly in the realm of CAR-T cell therapies aimed at improving patient outcomes in areas of high unmet need. One of their notable projects is the advancement of therapies targeting multiple myeloma, showcasing their commitment to pushing the boundaries of medicine. With a mission to transform the lives of patients by harnessing the power of cutting-edge science, Legend Biotech is dedicated to achieving breakthroughs that could redefine treatment paradigms. The company's work spans multiple continents, reflecting its global approach to tackling critical healthcare challenges.
Snapshot
Operations
Produtos e/ou serviços de Legend Biotech Corp
- CAR-T cell therapies for multiple myeloma, focusing on cilta-cel, a leading treatment providing significant remission rates in relapsed/refractory patients.
- Cell therapy technologies, including genetically engineered T cells targeting cancer-specific antigens for personalized patient care.
- Collaborative research and development agreements with pharmaceutical companies to advance cell therapy in oncology and beyond.
- Research in solid tumors aiming to expand the applicability of CAR-T and other cell therapies to a broader range of cancers.
- Manufacturing capabilities for cell therapies, ensuring quality control and scalability from clinical trials to commercialization.
- Pipeline development in hematology, expanding beyond multiple myeloma to address unmet needs in other blood cancers through innovative cell therapy approaches.
equipe executiva do Legend Biotech Corp
- Dr. Ying Huang Ph.D.CEO & Director
- Mr. Carlos SantosChief Financial Officer
- Ms. Jessie Yeung M.B.A.Vice President of Finance, Investor & Public Relations
- Mr. James Pepin J.D.General Counsel
- Mr. Tim RobertsGlobal Compliance Officer
- Ms. Elaine QianVP & Global Head of Human Resources
- Dr. Guowei Fang Ph.D.President of Research & Development
- Mr. Birk VanderweeenSenior Vice President of Global Manufacturing & Supply
- Mr. Alan S. BashPresident of CARVYKTI®
- Surabhi VermaManager of Investor Relations & Corporate Communications